Activation of T lymphocytes for adhesion and cytokine expression by toxin-conjugated anti-CD3 monoclonal antibodies

Transplantation

Volumn 68, Issue 5, 1999, Pages 693-698

  Hamawy, Majed M ^a   Tsuchida, Masahiro ^a   Manthei, Eric R ^a   Dong, Yinchen ^a   Fechner, John H ^a   Knechtle, Stuart J ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOTOXIN; INTERFERON; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; GENE EXPRESSION; INTERFERON PRODUCTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; RHESUS MONKEY; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; CELL ADHESION; CELL DIVISION; CYTOKINES; FIBRONECTINS; IMMUNOTOXINS; INTERFERON TYPE II; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MACACA MULATTA; MALE; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RNA, MESSENGER; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033568284     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199909150-00016     Document Type: Article

References (32)

1. Knechtle SJ, Vargo D, Fechner J, et al. FN18-CRM9 immunotoxin promotes tolerance in primate renal allografts. Transplantation 1997; 63: 1.
2. Fechner JHJ, Vargo DJ, Geissler EK, Wang J, Neville DMJ, Knechtle SJ. Mechanisms of tolerance induced by an immunotoxin against CD3 epsilon in a rhesus kidney allograft model. Transplant Proc 1997; 29: 1158.
3. Knechtle SJ, Fechner J, Dong Y, et al. Primate renal transplants using immunotoxin. Surgery 1998; 124: 438.
4. Thomas JM, Neville DM, Contreras JL, et al. Preclinical studies of allograft tolerance in rhesus monkeys: a novel anti-CD3-immunotoxin given peritransplant with donor bone marrow induces operational tolerance to kidney allografts. Transplantation 1997; 64: 124.
5. Hamawy MM, Knechtle SJ. Strategies for tolerance induction in non-human primates. Curr Opin Immunol 1998; 10: 513.
6. Neville DMJ, Scharff J, Hu HZ, et al. A new reagent for the induction of T-cell depletion, anti-CD3-CRM9. J Immunother 1985; 2: 85.
7. Fechner JHJ, Vargo DJ, Geissler EK, et al. Split tolerance induced by immunotoxin in a rhesus kidney allograft model. Transplantation 1997; 63: 1339.
8. Neville DMJ, Scharff J, Srinivasachar K. In vivo T-cell ablation by a holo-immunotoxin directed at human CD3. Proc Natl Acad Sci USA 1992; 89: 2585.
9. Neville DMJ. Immunotoxin: current use and future prospects in bone marrow transplantation and cancer treatment. Crit Rev Ther Drug Carr Sys 1986; 2: 329.
10. Cantrell D. T cell antigen receptor signal transduction pathways. Annu Rev Immunol 1996; 14: 259.
11. Qian D, Weiss A. T cell antigen receptor signal transduction. Curr Opin Cell Biol 1997; 9: 205.
12. Clevers H, Alarcon B, Wileman T, Terhorst C. The T cell receptor/CD3 complex: a dynamic protein ensemble. Annu Rev Immunol 1988; 6: 629.
13. Bolt S, Routledge E, Lloyd I, et al. The generation of a humanized, non-mitogenic CD3 monoclonal antibody which retains in vitro immunosuppressive properties. Eur J Immunol 1993; 23: 403.
14. Smith JA, Tso JY, Clark MR, Cole MS, Bluestone JA. Nonmitogenic anti-CD3 monoclonal antibodies deliver a partial T cell receptor signal and induce clonal anergy. J Exp Med 1997; 185: 1413.
15. Smith JA, Tang QH, Bluestone JA. Partial TCR signaling delivered by FcR-nonbinding anti-CD3 monoclonal antibodies differentially regulate individual Th subsets. J Immunol 1998; 160: 4841.
16. Hamawy MM. Mergenhagen SE, Siraganian RP. Cell adherence to fibronectin and the aggregation of the high affinity immunoglobulin E receptor synergistically regulate tyrosine phosphorylation of 105-115-kDa proteins. J Biol Chem 1993; 268: 5227.
17. Hamawy MM, Oliver C, Mergenhagen SE, Siraganian RP. Adherence of rat basophilic leukemia (RBL-2H3) cells to fibronectin-coated surfaces enhances secretion. J Immunol 1992; 149: 615.
18. Armstrong N, Buckley P. Oberley T, et al. Analysis of primate renal allografts after T-cell depletion with anti-CD3-CRM9. Transplantation 1998; 66: 5.
19. Hamawy MM, Mergenhagen SE, Siraganian RP. Protein tyrosine phosphorylation as a mechanism of signalling in mast cells and basophils. Cell Signal 1995; 7: 535.
20. Rozengurt E, Rodriguez-Fernandez JL. Tyrosine phosphorylation in the action of neuropeptides and growth factors. Essays Biochem 1997; 32: 73.
21. Minami Y, Taniguchi T. IL-2 signaling: recruitment and activation of multiple protein tyrosine kinases by the components of the IL-2 receptor. Curr Opin Cell Biol 1995; 7: 156.
22. Hamawy MM, Mergenhagen SE, Siraganian RP. Adhesion molecules as regulators of mast-cell and basophil function. Immunol Today 1994; 15: 62.
23. Halvorson MJ, Coligan JE, Sturnhofel K. The vitronectin receptor (alpha V beta 3) as an example for the role of integrins in T lymphocyte stimulation. Immunol Res 1996; 15: 16.
24. Shimizu Y, Shaw S. Lymphocyte interactions with extracellular matrix. FASEB J 1991; 5: 2292.
25. Springer TA. Adhesion receptors of the immune system. Nature 1990; 346: 425.
26. Maguire JE, Danahey KM, Burkly LC, van Seventer GA. T cell receptor- and beta 1 integrin-mediated signals synergize to induce tyrosine phosphorylation of focal adhesion kinase (pp125FAK) in human T cells. J Exp Med 1995; 182: 2079.
27. Newham P, Humphries MJ. Integrin adhesion receptors: structure, function and implications for biomedicine. Mol Med Today 1996; 2: 304.
28. Mohri H. Interaction of fibronectin with integrin receptors: evidence by use of synthetic peptides. Peptides 1997; 18: 899.
29. Paul WE. Pleiotropy and redundancy: T cell-derived lymphokines in the immune response. Cell 1989; 57: 521.
30. Groux H, Rouleau M, Bacchetta R, Roncarolo MG. T-cell subsets and their cytokine profiles in transplantation and tolerance. Ann NY Acad Sci 1995; 770: 141.
31. Theze J, Alzari PM, Bertoglio J. Interleukin 2 and its receptor: recent advance and new immunological functions. Immunol Today 1996; 17: 481.
32. Contreras JL, Wang PX, Eckhoff DE, et al. Peritransplant tolerance induction with anti-CD3-immunotoxin: a matter of proinflammatory cytokine control. Transplantation 1998; 9: 1159.